Post-market surveillancePeptide
Compound 61425
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061425
Risk Class
LOW
Last Audit
Feb 2, 2108
Research Abstract
Peptide candidate engineered for metabolic regulation initiatives with automated dossier coverage.
Compound 61425 is a peptide asset inside peptide innovation track initiatives, optimized for metabolic regulation and cardiometabolic recovery.
The dossier currently sits in post-market surveillance with a low risk rating, meaning it is cleared for baseline monitoring protocols.
Supply records cite CAS AUTO-061425 with updates logged 2108-02-02.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Metabolic regulationCardiometabolic recovery
Nomenclature
CX-61425Peptide Program 61425
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061425
- [2] Operations Pulse • Peptide innovation track
- [3] Risk Governance Ledger • LOW clearance for COMPOUND-61425